April 14, 2022

Equity Analysis

Artelo Biosciences, Inc. (ARTL) Stock Plunged 12.20% Today, Here’s Why

Artelo Biosciences, Inc. (ARTL) stock soared 12.20% in the current-market trading session at the price of $0.40. ARTL Published ART27.13 Results On 13th April 2022, ARTL announced positive pre-clinical results for ART27.13, a G-protein coupled receptor agonist in clinical development to treat cancer-based anorexia. The

Uncategorized

Biofrontera Inc. (BFRI) Stock Plunged 8.85% Pre-Market, Here’s Why

Biofrontera Inc. (BFRI) stock plummeted 8.85% in the pre-market trading session at the price of $4.52 following FDA approval of cGMP laboratory in Leverkusen. BFRI is a biopharmaceutical firm that develops and commercializes pharmaceutical products to treat dermatological conditions. The company’s approved products control

April 14, 2022

Artelo Biosciences, Inc. (ARTL) Stock Plunged 12.20% Today, Here’s Why

Biofrontera Inc. (BFRI) Stock Plunged 8.85% Pre-Market, Here’s Why

Quick Links

Categories

Get The Best Stocks To Trade Every Day!